ONABOTULINUMTOXINA SIGNIFICANTLY IMPROVES URINARY INCONTINENCE AND QUALITY OF LIFE IN OVERACTIVE BLADDER PATIENTS REGARDLESS OF INCONTINENCE SEVERITY AT BASELINE

被引：0
|
作者：
Ginsberg, D. [1 ]
Gruenenfelder, J. [2 ]
Moore, C. [3 ]
Kaufmann, A. [4 ]
Drake, M. [5 ]
Joshi, M. [6 ]
Magyar, A. [7 ]
Herschorn, S. [8 ]
机构：
[1] USC Inst Urol, Los Angeles, CA USA
[2] Orange Cty Urol Associates, Laguna Hills, CA USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Kliniken Maria Hilf GmbH, Monchengladbach, Germany
[5] Bristol Urol Inst, Bristol, Avon, England
[6] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
[7] Allergan Pharmaceut Inc, Bridgewater, NJ USA
[8] Univ Toronto, Toronto, ON, Canada
来源：
NEUROUROLOGY AND URODYNAMICS | 2015年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
167
引用
收藏
页码：S109 / S110
页数：2
相关论文
共 50 条
  • [41] OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
    Nitti, Victor W.
    Dmochowski, Roger
    Herschorn, Sender
    Sand, Peter
    Thompson, Catherine
    Nardo, Christopher
    Yan, Xiaohong
    Haag-Molkenteller, Cornelia
    [J]. JOURNAL OF UROLOGY, 2013, 189 (06): : 2186 - 2193
  • [42] AN ECONOMIC MODEL TO INVESTIGATE THE BUDGET IMPACT IN SPAIN OF ONABOTULINUMTOXINA TO MANAGE URINARY INCONTINENCE IN PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER
    Ruff, L.
    Zeidman, R.
    Aracil, J.
    Loveman, C.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A467 - A468
  • [43] Good treatment of urinary incontinence/overactive bladder
    不详
    [J]. AKTUELLE UROLOGIE, 2007, 38 (03) : 213 - 214
  • [44] Similar treatment effect with onabotulinumtoxin A in overactive bladder patients with urinary incontinence regardless of number of prior anticholinergics or reason for their inadequate management of patients' overactive bladder
    Junemann, Klaus-Peter
    Sievert, Karl-Dietrich
    Nitti, Victor
    Nardo, Christopher
    Zhou, Jihao
    Chapple, Christopher
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY, 2013, 47 : 34 - 35
  • [45] Definition of overactive bladder and epidemiology of urinary incontinence
    Hampel, C
    Wienhold, D
    Benken, N
    Eggersmann, C
    Thuroff, JW
    [J]. UROLOGY, 1997, 50 (6A) : 4 - 14
  • [46] ONABOTULINUMTOXINA REDUCES NOCTURNAL VOIDS AND IMPROVES QUALITY OF LIFE IN OVERACTIVE BLADDER PATIENTS WITH NOCTURIA
    Dmochowski, R.
    Ginsberg, D.
    Parsons, M.
    Robinson, D.
    Magyar, A.
    Nicandro, J.
    Drake, M.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S107 - S107
  • [47] Minimal clinically important change in urinary incontinence detected by a quality of life assessment tool in overactive bladder syndrome with urge incontinence
    Homma, Y
    Koyama, N
    [J]. NEUROUROLOGY AND URODYNAMICS, 2006, 25 (03) : 228 - 235
  • [48] Quality of life in patients with urinary incontinence
    Martinez Corcoles, B.
    Salinas Sanchez, A. S.
    Gimenez Bachs, J. M.
    Donate Moreno, M. J.
    Pastor Navarro, H.
    Virseda Rodriguez, J. A.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2008, 32 (02): : 202 - 210
  • [49] Botulinum toxin a improves the quality of life of patients with neurogenic urinary incontinence
    Schurch, Brigitte
    Denys, Pierre
    Kozma, Chris M.
    Reese, Pat Ray
    Slaton, Terra
    Barron, Richard L.
    [J]. EUROPEAN UROLOGY, 2007, 52 (03) : 850 - 859
  • [50] Effect of severity of urinary incontinence on quality of life in women
    Krhut, Jan
    Gartner, Marcel
    Mokris, Jan
    Horcicka, Lukas
    Svabik, Kamil
    Zachoval, Roman
    Martan, Alois
    Zvara, Peter
    [J]. NEUROUROLOGY AND URODYNAMICS, 2018, 37 (06) : 1925 - 1930
12345